• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征中的着床和蜕膜化:揭示妊娠的复杂性。

Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy.

机构信息

Reproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

出版信息

Int J Mol Sci. 2024 Jan 18;25(2):1203. doi: 10.3390/ijms25021203.

DOI:10.3390/ijms25021203
PMID:38256276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10816633/
Abstract

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder in women of reproductive age, affecting 5-15% globally with a large proportion undiagnosed. This review explores the multifaceted nature of PCOS and its impact on pregnancy, including challenges in fertility due to hormonal imbalances and insulin resistance. Despite restoring ovulation pharmacologically, women with PCOS face lower pregnancy rates and higher risks of implantation failure and miscarriage. Our review focuses on the complexities of hormonal and metabolic imbalances that impair endometrial receptivity and decidualization in PCOS. Disrupted estrogen signaling, reduced integrity of endometrial epithelial tight junctions, and insulin resistance impair the window of endometrial receptivity. Furthermore, progesterone resistance adversely affects decidualization. Our review also examines the roles of various immune cells and inflammatory processes in the endometrium, contributing to the condition's reproductive challenges. Lastly, we discuss the use of rodent models in understanding PCOS, particularly those induced by hormonal interventions, offering insights into the syndrome's impact on pregnancy and potential treatments. This comprehensive review underscores the need for advanced understanding and treatment strategies to address the reproductive complications associated with PCOS, emphasizing its intricate interplay of hormonal, metabolic, and immune factors.

摘要

多囊卵巢综合征(PCOS)是一种常见的育龄期女性内分泌疾病,全球范围内发病率为 5-15%,其中很大一部分未被诊断。本综述探讨了 PCOS 的多面性及其对妊娠的影响,包括由于激素失衡和胰岛素抵抗导致的生育挑战。尽管通过药理学恢复排卵,但 PCOS 患者的妊娠率较低,着床失败和流产的风险较高。我们的综述重点关注了激素和代谢失衡对 PCOS 中子宫内膜容受性和蜕膜化的影响。雌激素信号转导受损、子宫内膜上皮紧密连接完整性降低以及胰岛素抵抗会损害子宫内膜容受性窗口。此外,孕激素抵抗也会对蜕膜化产生不利影响。我们的综述还研究了各种免疫细胞和炎症过程在子宫内膜中的作用,这些过程导致了该病症的生殖挑战。最后,我们讨论了使用啮齿动物模型来理解 PCOS 的作用,特别是那些由激素干预引起的模型,这些模型为理解 PCOS 对妊娠的影响和潜在治疗方法提供了深入的见解。本综述强调了需要深入了解和治疗策略来解决与 PCOS 相关的生殖并发症,重点强调了其激素、代谢和免疫因素的复杂相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c7/10816633/9fb4f9d2cfaf/ijms-25-01203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c7/10816633/8cbe9c0ae41a/ijms-25-01203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c7/10816633/9fb4f9d2cfaf/ijms-25-01203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c7/10816633/8cbe9c0ae41a/ijms-25-01203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c7/10816633/9fb4f9d2cfaf/ijms-25-01203-g002.jpg

相似文献

1
Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy.多囊卵巢综合征中的着床和蜕膜化:揭示妊娠的复杂性。
Int J Mol Sci. 2024 Jan 18;25(2):1203. doi: 10.3390/ijms25021203.
2
Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro.多囊卵巢综合征女性的子宫内膜基质成纤维细胞存在孕酮介导的蜕膜化受损、细胞因子谱异常,并在体外促进免疫细胞迁移增强。
Hum Reprod. 2015 May;30(5):1203-15. doi: 10.1093/humrep/dev055. Epub 2015 Mar 6.
3
Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.高雄激素血症伴胰岛素抵抗的孕鼠,其子宫雄激素受体蛋白含量增加,导致胚胎着床和线粒体缺陷。
J Mol Med (Berl). 2021 Oct;99(10):1427-1446. doi: 10.1007/s00109-021-02104-z. Epub 2021 Jun 28.
4
An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome.多囊卵巢综合征患者子宫内膜容受性的研究进展更新。
Reprod Sci. 2022 Aug;29(8):2136-2144. doi: 10.1007/s43032-021-00641-z. Epub 2021 Jun 2.
5
Basic aspects of endometrial receptivity in PCOS patients.多囊卵巢综合征患者的子宫内膜容受性基础。
Mol Biol Rep. 2022 Feb;49(2):1519-1528. doi: 10.1007/s11033-021-06976-9. Epub 2022 Jan 6.
6
Endometrium in PCOS: Implantation and predisposition to endocrine CA.多囊卵巢综合征中的子宫内膜:着床与内分泌癌易感性
Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):235-44. doi: 10.1016/j.beem.2006.03.005.
7
Decreased AMPK/SIRT1/PDK4 induced by androgen excess inhibits human endometrial stromal cell decidualization in PCOS.雄激素过多导致的 AMPK/SIRT1/PDK4 减少抑制了 PCOS 中人类子宫内膜基质细胞的蜕膜化。
Cell Mol Life Sci. 2024 Jul 30;81(1):324. doi: 10.1007/s00018-024-05362-5.
8
Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.低剂量他克莫司治疗多囊卵巢综合征异常子宫内膜特征的疗效。
Int J Mol Sci. 2021 Mar 12;22(6):2872. doi: 10.3390/ijms22062872.
9
Polycystic ovary syndrome: Endometrial markers.多囊卵巢综合征:子宫内膜标志物
Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:66-79. doi: 10.1016/j.bpobgyn.2016.03.008. Epub 2016 Apr 1.
10
The Endometrial Transcriptome of Metabolic and Inflammatory Pathways During the Window of Implantation Is Deranged in Infertile Obese Polycystic Ovarian Syndrome Women.在着床窗口期,代谢和炎症途径的子宫内膜转录组在不孕肥胖多囊卵巢综合征妇女中出现紊乱。
Metab Syndr Relat Disord. 2022 Sep;20(7):384-394. doi: 10.1089/met.2021.0149. Epub 2022 Jul 13.

引用本文的文献

1
The efficacy of RNA-seq-based endometrial receptivity test (rsERT) in guiding personalized embryo transfer in women with polycystic ovarian syndrome without recurrent implantation failure: a randomized controlled trial.基于RNA测序的子宫内膜容受性检测(rsERT)在指导无反复种植失败的多囊卵巢综合征女性进行个性化胚胎移植中的疗效:一项随机对照试验。
J Assist Reprod Genet. 2025 Sep 13. doi: 10.1007/s10815-025-03627-x.
2
Changes in Epithelial Cell Polarity and Adhesion Guide Human Endometrial Receptivity: How In Vitro Systems Help to Untangle Mechanistic Details.上皮细胞极性和黏附的变化指导人类子宫内膜容受性:体外系统如何助力解析机制细节
Biomolecules. 2025 Jul 22;15(8):1057. doi: 10.3390/biom15081057.
3

本文引用的文献

1
Contemporary Management of the Patient with Polycystic Ovary Syndrome.多囊卵巢综合征患者的当代管理。
Obstet Gynecol Clin North Am. 2023 Dec;50(4):695-705. doi: 10.1016/j.ogc.2023.08.003. Epub 2023 Sep 15.
2
Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility.二甲双胍在多囊卵巢综合征(PCOS)相关性不孕症中的作用。
Cureus. 2023 Aug 31;15(8):e44493. doi: 10.7759/cureus.44493. eCollection 2023 Aug.
3
Defective Uterine Spiral Artery Remodeling and Placental Senescence in a Pregnant Rat Model of Polycystic Ovary Syndrome.
MicroRNA Signatures in Endometrial Receptivity-Unlocking Their Role in Embryo Implantation and IVF Success: A Systematic Review.
子宫内膜容受性中的微小RNA特征——揭示它们在胚胎着床和体外受精成功中的作用:一项系统综述
Biomedicines. 2025 May 13;13(5):1189. doi: 10.3390/biomedicines13051189.
4
Exploring the mechanism of action of aspirin in improving endometrial receptivity in PCOS rats based on uterine lavage fluid metabolomics.基于子宫灌洗液代谢组学探究阿司匹林改善多囊卵巢综合征大鼠子宫内膜容受性的作用机制
PLoS One. 2025 May 22;20(5):e0324432. doi: 10.1371/journal.pone.0324432. eCollection 2025.
5
Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers.靶向UGT2B15与NR1H4的相互作用:使用萘哌地尔对映体治疗多囊卵巢综合征的新策略。
J Ovarian Res. 2025 Jan 24;18(1):13. doi: 10.1186/s13048-025-01598-2.
6
Effect of basal luteinizing hormone/follicle-stimulating hormone ratio on clinical outcome of fertilization in patients with polycystic ovarian syndrome: a retrospective cohort study.基础促黄体生成素/促卵泡生成素比值对多囊卵巢综合征患者受精临床结局的影响:一项回顾性队列研究
PeerJ. 2024 Nov 26;12:e18635. doi: 10.7717/peerj.18635. eCollection 2024.
7
Therapeutic potential of endometrial stem cells encapsulated in alginate/gelatin hydrogel to treat of polycystic ovary syndrome.包裹在藻酸盐/明胶水凝胶中的子宫内膜干细胞治疗多囊卵巢综合征的潜力
Regen Ther. 2024 Aug 30;26:693-707. doi: 10.1016/j.reth.2024.08.016. eCollection 2024 Jun.
8
Metformin administration during pregnancy tends to reduce the risk of gestational diabetes mellitus and improve pregnancy outcomes in previously infertile women with polycystic ovary syndrome who become pregnant.孕期服用二甲双胍往往会降低多囊卵巢综合征所致既往不孕的孕妇患妊娠期糖尿病的风险,并改善妊娠结局。
Ir J Med Sci. 2024 Dec;193(6):2843-2849. doi: 10.1007/s11845-024-03760-z. Epub 2024 Jul 20.
9
Usefulness of the Sympto-Thermal Method with Standardized Cervical Mucus Assessment (InVivo Method) for Evaluating the Monthly Cycle in Women with Polycystic Ovary Syndrome (PCOS).采用标准化宫颈黏液评估的症状体温法(体内法)评估多囊卵巢综合征(PCOS)女性月经周期的效用。
Healthcare (Basel). 2024 May 29;12(11):1108. doi: 10.3390/healthcare12111108.
多囊卵巢综合征孕鼠模型中子宫螺旋动脉重塑缺陷和胎盘衰老。
Am J Pathol. 2023 Dec;193(12):1916-1935. doi: 10.1016/j.ajpath.2023.08.008. Epub 2023 Sep 7.
4
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见。
Fertil Steril. 2023 Oct;120(4):767-793. doi: 10.1016/j.fertnstert.2023.07.025. Epub 2023 Aug 14.
5
An interplay of Progesterone, Leukemia Inhibitor Factor and Interleukin-6 in the window of implantation; Impact on fertility.孕激素、白血病抑制因子和白细胞介素-6在着床窗口的相互作用;对生育能力的影响。
Cytokine. 2023 Oct;170:156332. doi: 10.1016/j.cyto.2023.156332. Epub 2023 Aug 14.
6
Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review.高雄激素血症及其对子宫内膜容受性的可能影响:综述。
Int J Mol Sci. 2023 Jul 27;24(15):12026. doi: 10.3390/ijms241512026.
7
Immune Cell Functionality during Decidualization and Potential Clinical Application.蜕膜化过程中的免疫细胞功能及潜在临床应用
Life (Basel). 2023 Apr 27;13(5):1097. doi: 10.3390/life13051097.
8
Dysregulation of immune response in PCOS organ system.多囊卵巢综合征器官系统中免疫反应失调。
Front Immunol. 2023 May 5;14:1169232. doi: 10.3389/fimmu.2023.1169232. eCollection 2023.
9
Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome-Case Report.月经周期生物标志物在多囊卵巢综合征不孕症治疗中的成功应用——病例报告
Healthcare (Basel). 2023 Feb 18;11(4):616. doi: 10.3390/healthcare11040616.
10
An In Vivo Screening Model for Investigation of Pathophysiology of Human Implantation Failure.一种用于研究人类着床失败病理生理学的体内筛选模型。
Biomolecules. 2022 Dec 30;13(1):79. doi: 10.3390/biom13010079.